(株)VC Cell Therapy
Advancing regenerative medicine with pioneering research in cell production robotics and AI, while innovating retinal cell therapies to enhance patient care.
Advancing regenerative medicine with pioneering research in cell production robotics and AI, while innovating retinal cell therapies to enhance patient care.
VC Cell Therapy is a pioneering company in the regenerative medicine industry, leveraging cutting-edge research in cell production robotics and AI to advance the field. The company's focus on enhancing patient care through innovative retinal cell therapies sets it apart in the Health Care and Pharmaceutical industries. Founded in 2021, VC Cell Therapy recently secured a significant ¥600.00M investment in a Venture Round on 15 November 2023, with notable investors including Dai-Dan, Sysmex Corporation, and YASKAWA Electric. This injection of funds positions the company well to continue its groundbreaking work at the intersection of technology and regenerative medicine, offering promising prospects for the future of healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | ¥600.00M | 3 | Dai-Dan, Sysmex Corporation +1 | 15 Nov 2023 |
| Venture Round | Unknown | 1 | YASKAWA Electric | 21 May 2021 |
No recent news or press coverage available for (株)VC Cell Therapy.
We care about your data, and we'd love to use cookies make your experience better.